Christopher Browning, OD, and Nicholas Garn, OD, now offer cataract surgery and refractive lens exchange in their own practices.
|Videos|June 6, 2018
The impact of exercise on glaucoma
Author(s)Benjamin P. Casella, OD, FAAO
Optometry Times Chief Optometric Editor Benjamin P. Casella, OD, FAAO, discusses how exercises including yoga impact patients who have glaucoma.
Advertisement
The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or UBM Medica.
Optometry Times Chief Optometric Editor Benjamin P. Casella, OD, FAAO, discusses how exercises including yoga impact patients who have glaucoma.
Advertisement
Related to this article
According to Raphael Rostenne, CTO of EyeCarePro, "anything that takes time" has the potential to frustrate patients, especially before they're in a practitioner's chair.
Amanda Nanasy, OD, discussed how sports can open the door to eye care for underserved athletes and what goes into her performance vision evaluations.
Raphael Rostenne discusses what a good phone call looks like and contributes to successful patient interactions with host Diana Canto-Sims, OD.
Amanda Nanasy, OD, described how her own concussion shaped her approach to athletes and why she ties every vision evaluation back to the demands of their sport.
Open-access OCTA tools showed similar reliability, but different vessel density values in glaucoma; researchers advise using one tool consistently.
Interim 48-month data show 86% of patients with glaucoma or ocular hypertension remain off topical drops after a single cataract procedure, although the drop-free rate has eased from earlier time points.
Diana Canto-Sims, OD, introduces the second guest of Season 2, Raphael Rostenne, who will be discussing AI-assisted front desk management.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Indiana optometrists open state’s first OD-owned surgical suites
2
2027 Medicare fee schedule trims same-day E/M, 0-day procedure pay
3
Takeaways from this week in optometry: November 2-6
4
FDA approves ranibizumab biosimilar Lucamzi for wet AMD
5